Abukahel Areen, Aldiwanie Ahmad S, AlRyalat Saif Aldeen, Gharaibeh Almutez M
Department of Ophthalmology, Jordan University Hospital, The University of Jordan, Amman, Jordan.
Med Hypothesis Discov Innov Ophthalmol. 2022 Apr 1;11(1):27-33. doi: 10.51329/mehdiophthal1442. eCollection 2022 Spring.
Pediatric corneal transplantation can be indicated in congenital and acquired conditions. Challenges include preoperative evaluation, multiple intraoperative obstacles, and postoperative problems in follow-up and management. This study was aimed at identifying the indications and clinical outcomes of pediatric penetrating keratoplasty (PKP) in Jordan.
This retrospective cohort study was conducted in Amman, Jordan. Using the hospital's electronic database, all medical records of patients aged < 18 years who underwent PKP between January 2004 and October 2019 were reviewed. Preoperative evaluations included best-corrected distance visual acuity (BCDVA) and anterior and posterior segment examinations. Postoperative complications, BCDVA, and graft survival were examined 1 year postoperatively.
A total of 149 cases of pediatric PKP were performed on 141 eyes of 118 patients with an age mean ± standard deviation (SD) of 11.44 ± 4.97 years at the time of surgery. Acquired non-traumatic corneal pathologies accounted for 65.8% of indications for PKP. The most frequent indication was advanced keratoconus (55.7%). Preoperative and 1-year postoperative BCDVAs significantly differed (P < 0.001), with 111 (74.5%) patients showing improved BCDVA, 12 (8.05%) patients showing worsened BCDVA, and 26 (17.45%) patients showing no change in BCDVA. The overall 1-year graft survival rate was 80.54%.
This was the largest study in Jordan involving pediatric patients who underwent PKP for various indications, showing a significant improvement in BCDVA, with a high survival rate at 1 year. Future studies with longer follow-up periods could provide stronger evidence for surgical outcomes and graft survival. Further, the option of lamellar keratoplasty in the pediatric age group should be assessed.
小儿角膜移植可用于先天性和后天性疾病。挑战包括术前评估、术中的多种障碍以及术后随访和管理中的问题。本研究旨在确定约旦小儿穿透性角膜移植术(PKP)的适应证和临床结果。
这项回顾性队列研究在约旦安曼进行。利用医院的电子数据库,回顾了2004年1月至2019年10月期间接受PKP的18岁以下患者的所有病历。术前评估包括最佳矫正远视力(BCDVA)以及眼前段和眼后段检查。术后1年检查术后并发症、BCDVA和植片存活率。
共对118例患者的141只眼进行了149例小儿PKP手术,手术时患者的平均年龄±标准差(SD)为11.44±4.97岁。后天性非创伤性角膜病变占PKP适应证的65.8%。最常见的适应证是晚期圆锥角膜(55.7%)。术前和术后1年的BCDVA有显著差异(P<0.001),111例(74.5%)患者的BCDVA改善,12例(8.05%)患者的BCDVA恶化,26例(17.45%)患者的BCDVA无变化。总体1年植片存活率为80.54%。
这是约旦规模最大的一项涉及因各种适应证接受PKP的小儿患者的研究,显示BCDVA有显著改善,1年存活率较高。未来进行更长随访期的研究可为手术结果和植片存活提供更有力的证据。此外,应评估小儿年龄组板层角膜移植术的选择。